GHB16L2 Trivalent Influenza Vaccine

· AVIR Green Hills Biotechnology AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GHB16L2 Trivalent Influenza Vaccine, covering 2014-01-10 to 2014-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults [Phase 1, Phase 2]